Loading…

Healthcare costs attributable to e-cigarette use and subsequent uptake of cigarette smoking by Australians who have never smoked

Objective. New legislation to curb the rapid increase in e-cigarette use among youth is underway. We estimated the future healthcare costs for chronic diseases from e-cigarette use among never smokers who transition to tobacco smoking. Methods. Using populationattributable fractions, we estimated th...

Full description

Saved in:
Bibliographic Details
Published in:Australian health review 2024-02, Vol.48 (1), p.52-57
Main Authors: Gordon, Louisa G., Preston, Paige
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 57
container_issue 1
container_start_page 52
container_title Australian health review
container_volume 48
creator Gordon, Louisa G.
Preston, Paige
description Objective. New legislation to curb the rapid increase in e-cigarette use among youth is underway. We estimated the future healthcare costs for chronic diseases from e-cigarette use among never smokers who transition to tobacco smoking. Methods. Using populationattributable fractions, we estimated the health expenditure attributable to e-cigarettes based on the prevalence of e-cigarette use, uptake of tobacco smoking, and risk of smoking on developing chronic disease. Data for men and women were derived from published reports on e-cigarette use prevalence, risk of smoking-related disease and addiction, and health expenditure for 25 diseases. Sensitivity analyses were undertaken to address data input variation. Results. Future healthcare costs attributed to new e-cigarette-initiated smokers were conservatively estimated to be (in Australian dollars) $179.6 million annually. Collectively, the estimated costs were highest for respiratory diseases ($102.2 million; 57% of total costs), malignant cancers ($49.6 million; 28%), and cardiovascular disease ($27.7 million; 15%). The uptake rate of e-cigarettes was more important in driving healthcare costs than the proportion moving from e-cigarettes to cigarette smoking. Conclusion. High avoidable health system costs are predicted for the treatment of chronic conditions created by e-cigarette-initiated smoking. These costs exclude the immediate and direct healthcare harms of e-cigarette-related poisoning, lung injury, and respiratory problems, and costs associated with the unknown health harms of e-cigarette use alone. The proposed regulations to curb recreational e-cigarette use in Australia are set to prevent expensive health care arising sometime in the future from new cigarette smokers.
doi_str_mv 10.1071/AH23178
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2929145758</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2929145758</sourcerecordid><originalsourceid>FETCH-LOGICAL-c271t-41410c1f7635ef2b163f418ee596336b23bac8e659787848adcc00f24e4edc113</originalsourceid><addsrcrecordid>eNpFkDFPwzAUhC0EEqUg_oIlBqaAX2zHzlhVQJEqscAcOc5LkzaNi-0UdeOnE2glphvu093pCLkF9gBMweNskXJQ-oxMQIg80bkQ52TCQGaJVFpfkqsQ1oxBLnU2Id8LNF1srPFIrQsxUBOjb8shmrJDGh3FxLar0Y4R6RCQmr6iYSgDfg7YRzrsotkgdTX9x8LWbdp-RcsDnQ0hetO1pg_0q3G0MXukPe7R_1FYXZOL2nQBb046JR_PT-_zRbJ8e3mdz5aJTRXERIAAZqFWGZdYpyVkvBagEWWecZ6VKS-N1ZjJXGmlhTaVtYzVqUCBlQXgU3J3zN15Ny4PsVi7wfdjZZHmaQ5CKqlH6v5IWe9C8FgXO99ujT8UwIrfe4vTvfwHXzVuKA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2929145758</pqid></control><display><type>article</type><title>Healthcare costs attributable to e-cigarette use and subsequent uptake of cigarette smoking by Australians who have never smoked</title><source>ABI/INFORM Global</source><creator>Gordon, Louisa G. ; Preston, Paige</creator><creatorcontrib>Gordon, Louisa G. ; Preston, Paige</creatorcontrib><description>Objective. New legislation to curb the rapid increase in e-cigarette use among youth is underway. We estimated the future healthcare costs for chronic diseases from e-cigarette use among never smokers who transition to tobacco smoking. Methods. Using populationattributable fractions, we estimated the health expenditure attributable to e-cigarettes based on the prevalence of e-cigarette use, uptake of tobacco smoking, and risk of smoking on developing chronic disease. Data for men and women were derived from published reports on e-cigarette use prevalence, risk of smoking-related disease and addiction, and health expenditure for 25 diseases. Sensitivity analyses were undertaken to address data input variation. Results. Future healthcare costs attributed to new e-cigarette-initiated smokers were conservatively estimated to be (in Australian dollars) $179.6 million annually. Collectively, the estimated costs were highest for respiratory diseases ($102.2 million; 57% of total costs), malignant cancers ($49.6 million; 28%), and cardiovascular disease ($27.7 million; 15%). The uptake rate of e-cigarettes was more important in driving healthcare costs than the proportion moving from e-cigarettes to cigarette smoking. Conclusion. High avoidable health system costs are predicted for the treatment of chronic conditions created by e-cigarette-initiated smoking. These costs exclude the immediate and direct healthcare harms of e-cigarette-related poisoning, lung injury, and respiratory problems, and costs associated with the unknown health harms of e-cigarette use alone. The proposed regulations to curb recreational e-cigarette use in Australia are set to prevent expensive health care arising sometime in the future from new cigarette smokers.</description><identifier>ISSN: 0156-5788</identifier><identifier>EISSN: 1449-8944</identifier><identifier>DOI: 10.1071/AH23178</identifier><language>eng</language><publisher>Collingwood: CSIRO</publisher><subject>Chemicals ; Chronic illnesses ; Costs ; Disease ; Electronic cigarettes ; Health care expenditures ; Legislation ; Nicotine ; Poisoning ; Poisons ; Public health ; Smoking cessation ; Tobacco ; Toxicity ; Trends ; Vaping ; Womens health</subject><ispartof>Australian health review, 2024-02, Vol.48 (1), p.52-57</ispartof><rights>Copyright CSIRO Feb 2024</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0000-0002-3159-4249</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2929145758/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$H</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2929145758?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,780,784,11688,27924,27925,36060,44363,74895</link.rule.ids></links><search><creatorcontrib>Gordon, Louisa G.</creatorcontrib><creatorcontrib>Preston, Paige</creatorcontrib><title>Healthcare costs attributable to e-cigarette use and subsequent uptake of cigarette smoking by Australians who have never smoked</title><title>Australian health review</title><description>Objective. New legislation to curb the rapid increase in e-cigarette use among youth is underway. We estimated the future healthcare costs for chronic diseases from e-cigarette use among never smokers who transition to tobacco smoking. Methods. Using populationattributable fractions, we estimated the health expenditure attributable to e-cigarettes based on the prevalence of e-cigarette use, uptake of tobacco smoking, and risk of smoking on developing chronic disease. Data for men and women were derived from published reports on e-cigarette use prevalence, risk of smoking-related disease and addiction, and health expenditure for 25 diseases. Sensitivity analyses were undertaken to address data input variation. Results. Future healthcare costs attributed to new e-cigarette-initiated smokers were conservatively estimated to be (in Australian dollars) $179.6 million annually. Collectively, the estimated costs were highest for respiratory diseases ($102.2 million; 57% of total costs), malignant cancers ($49.6 million; 28%), and cardiovascular disease ($27.7 million; 15%). The uptake rate of e-cigarettes was more important in driving healthcare costs than the proportion moving from e-cigarettes to cigarette smoking. Conclusion. High avoidable health system costs are predicted for the treatment of chronic conditions created by e-cigarette-initiated smoking. These costs exclude the immediate and direct healthcare harms of e-cigarette-related poisoning, lung injury, and respiratory problems, and costs associated with the unknown health harms of e-cigarette use alone. The proposed regulations to curb recreational e-cigarette use in Australia are set to prevent expensive health care arising sometime in the future from new cigarette smokers.</description><subject>Chemicals</subject><subject>Chronic illnesses</subject><subject>Costs</subject><subject>Disease</subject><subject>Electronic cigarettes</subject><subject>Health care expenditures</subject><subject>Legislation</subject><subject>Nicotine</subject><subject>Poisoning</subject><subject>Poisons</subject><subject>Public health</subject><subject>Smoking cessation</subject><subject>Tobacco</subject><subject>Toxicity</subject><subject>Trends</subject><subject>Vaping</subject><subject>Womens health</subject><issn>0156-5788</issn><issn>1449-8944</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>M0C</sourceid><recordid>eNpFkDFPwzAUhC0EEqUg_oIlBqaAX2zHzlhVQJEqscAcOc5LkzaNi-0UdeOnE2glphvu093pCLkF9gBMweNskXJQ-oxMQIg80bkQ52TCQGaJVFpfkqsQ1oxBLnU2Id8LNF1srPFIrQsxUBOjb8shmrJDGh3FxLar0Y4R6RCQmr6iYSgDfg7YRzrsotkgdTX9x8LWbdp-RcsDnQ0hetO1pg_0q3G0MXukPe7R_1FYXZOL2nQBb046JR_PT-_zRbJ8e3mdz5aJTRXERIAAZqFWGZdYpyVkvBagEWWecZ6VKS-N1ZjJXGmlhTaVtYzVqUCBlQXgU3J3zN15Ny4PsVi7wfdjZZHmaQ5CKqlH6v5IWe9C8FgXO99ujT8UwIrfe4vTvfwHXzVuKA</recordid><startdate>202402</startdate><enddate>202402</enddate><creator>Gordon, Louisa G.</creator><creator>Preston, Paige</creator><general>CSIRO</general><scope>AAYXX</scope><scope>CITATION</scope><scope>0U~</scope><scope>1-H</scope><scope>3V.</scope><scope>4T-</scope><scope>4U-</scope><scope>7RO</scope><scope>7RV</scope><scope>7WY</scope><scope>7WZ</scope><scope>7X7</scope><scope>7XB</scope><scope>87Z</scope><scope>88C</scope><scope>88E</scope><scope>8AI</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8FL</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AXJJW</scope><scope>AYAGU</scope><scope>BENPR</scope><scope>BEZIV</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FREBS</scope><scope>FRNLG</scope><scope>FYUFA</scope><scope>F~G</scope><scope>GHDGH</scope><scope>K60</scope><scope>K6~</scope><scope>K9.</scope><scope>KB0</scope><scope>L.-</scope><scope>L.0</scope><scope>M0C</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQBIZ</scope><scope>PQBZA</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><orcidid>https://orcid.org/0000-0002-3159-4249</orcidid></search><sort><creationdate>202402</creationdate><title>Healthcare costs attributable to e-cigarette use and subsequent uptake of cigarette smoking by Australians who have never smoked</title><author>Gordon, Louisa G. ; Preston, Paige</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c271t-41410c1f7635ef2b163f418ee596336b23bac8e659787848adcc00f24e4edc113</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Chemicals</topic><topic>Chronic illnesses</topic><topic>Costs</topic><topic>Disease</topic><topic>Electronic cigarettes</topic><topic>Health care expenditures</topic><topic>Legislation</topic><topic>Nicotine</topic><topic>Poisoning</topic><topic>Poisons</topic><topic>Public health</topic><topic>Smoking cessation</topic><topic>Tobacco</topic><topic>Toxicity</topic><topic>Trends</topic><topic>Vaping</topic><topic>Womens health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gordon, Louisa G.</creatorcontrib><creatorcontrib>Preston, Paige</creatorcontrib><collection>CrossRef</collection><collection>Global News &amp; ABI/Inform Professional</collection><collection>Trade PRO</collection><collection>ProQuest Central (Corporate)</collection><collection>Docstoc</collection><collection>University Readers</collection><collection>Asian Business Database</collection><collection>ProQuest Nursing and Allied Health Journals</collection><collection>ABI/INFORM Collection</collection><collection>ABI/INFORM Global (PDF only)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ABI/INFORM Global (Alumni Edition)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Asian Business Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ABI/INFORM Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>Asian &amp; European Business Collection</collection><collection>Australia &amp; New Zealand Database</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Business Premium Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Asian &amp; European Business Collection (Alumni)</collection><collection>Business Premium Collection (Alumni)</collection><collection>Health Research Premium Collection</collection><collection>ABI/INFORM Global (Corporate)</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Business Collection (Alumni Edition)</collection><collection>ProQuest Business Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ABI/INFORM Professional Advanced</collection><collection>ABI/INFORM Professional Standard</collection><collection>ABI/INFORM Global</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Business</collection><collection>ProQuest One Business (Alumni)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><jtitle>Australian health review</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gordon, Louisa G.</au><au>Preston, Paige</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Healthcare costs attributable to e-cigarette use and subsequent uptake of cigarette smoking by Australians who have never smoked</atitle><jtitle>Australian health review</jtitle><date>2024-02</date><risdate>2024</risdate><volume>48</volume><issue>1</issue><spage>52</spage><epage>57</epage><pages>52-57</pages><issn>0156-5788</issn><eissn>1449-8944</eissn><abstract>Objective. New legislation to curb the rapid increase in e-cigarette use among youth is underway. We estimated the future healthcare costs for chronic diseases from e-cigarette use among never smokers who transition to tobacco smoking. Methods. Using populationattributable fractions, we estimated the health expenditure attributable to e-cigarettes based on the prevalence of e-cigarette use, uptake of tobacco smoking, and risk of smoking on developing chronic disease. Data for men and women were derived from published reports on e-cigarette use prevalence, risk of smoking-related disease and addiction, and health expenditure for 25 diseases. Sensitivity analyses were undertaken to address data input variation. Results. Future healthcare costs attributed to new e-cigarette-initiated smokers were conservatively estimated to be (in Australian dollars) $179.6 million annually. Collectively, the estimated costs were highest for respiratory diseases ($102.2 million; 57% of total costs), malignant cancers ($49.6 million; 28%), and cardiovascular disease ($27.7 million; 15%). The uptake rate of e-cigarettes was more important in driving healthcare costs than the proportion moving from e-cigarettes to cigarette smoking. Conclusion. High avoidable health system costs are predicted for the treatment of chronic conditions created by e-cigarette-initiated smoking. These costs exclude the immediate and direct healthcare harms of e-cigarette-related poisoning, lung injury, and respiratory problems, and costs associated with the unknown health harms of e-cigarette use alone. The proposed regulations to curb recreational e-cigarette use in Australia are set to prevent expensive health care arising sometime in the future from new cigarette smokers.</abstract><cop>Collingwood</cop><pub>CSIRO</pub><doi>10.1071/AH23178</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0002-3159-4249</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0156-5788
ispartof Australian health review, 2024-02, Vol.48 (1), p.52-57
issn 0156-5788
1449-8944
language eng
recordid cdi_proquest_journals_2929145758
source ABI/INFORM Global
subjects Chemicals
Chronic illnesses
Costs
Disease
Electronic cigarettes
Health care expenditures
Legislation
Nicotine
Poisoning
Poisons
Public health
Smoking cessation
Tobacco
Toxicity
Trends
Vaping
Womens health
title Healthcare costs attributable to e-cigarette use and subsequent uptake of cigarette smoking by Australians who have never smoked
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T21%3A31%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Healthcare%20costs%20attributable%20to%20e-cigarette%20use%20and%20subsequent%20uptake%20of%20cigarette%20smoking%20by%20Australians%20who%20have%20never%20smoked&rft.jtitle=Australian%20health%20review&rft.au=Gordon,%20Louisa%20G.&rft.date=2024-02&rft.volume=48&rft.issue=1&rft.spage=52&rft.epage=57&rft.pages=52-57&rft.issn=0156-5788&rft.eissn=1449-8944&rft_id=info:doi/10.1071/AH23178&rft_dat=%3Cproquest_cross%3E2929145758%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c271t-41410c1f7635ef2b163f418ee596336b23bac8e659787848adcc00f24e4edc113%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2929145758&rft_id=info:pmid/&rfr_iscdi=true